实用老年医学 ›› 2025, Vol. 39 ›› Issue (4): 372-376.doi: 10.3969/j.issn.1003-9198.2025.04.010
郑卉, 王惠, 尹冬华, 尹红丽, 孙楚乔, 程阳, 王颖
收稿日期:
2024-05-31
出版日期:
2025-04-20
发布日期:
2025-04-22
通讯作者:
王颖,Email:wangying5069@126.com
基金资助:
ZHENG Hui, WANG Hui, YIN Donghua, YIN Hongli, SUN Chuqiao,CHENG Yang, WANG Ying
Received:
2024-05-31
Online:
2025-04-20
Published:
2025-04-22
Contact:
WANG Ying,Email:wangying5069@126.com
摘要: 目的 比较多种肥胖相关人体测量指数在预测心血管疾病(cardiovascular disease, CVD)风险方面的效能,并确定最佳指标的最佳阈值。 方法 本项横断面研究调查了1 702例居住在中国南京城市地区年龄>60岁的绝经后女性。记录8项肥胖相关人体测量指数,包括体质量指数、腰围、腰臀比、腰高比、腹部容积指数、身体肥胖指数、体圆度指数和体型指数。采用多因素logistic回归分析评估10年CVD风险与所有指标之间的相关性。采用ROC曲线和AUC评估所有指标对CVD风险的预测能力。 结果 在这些绝经后女性中,691例(40.6%)被评估为CVD中风险,406例(23.9%)被评估为CVD高风险。有中高CVD风险的人具有更高水平的肥胖相关人体测量指数。多因素logistic回归分析结果显示,除体型指数外,其余所有肥胖相关人体测量指数均与CVD风险相关。ROC曲线分析显示,身体圆度指数和腰高比对CVD风险有更优的筛查性能,最佳阈值分别为3.85和0.52。 结论 身体圆度指数和腰高比是评估绝经后女性CVD风险的最佳人体测量指标。
中图分类号:
郑卉, 王惠, 尹冬华, 尹红丽, 孙楚乔, 程阳, 王颖. 绝经后女性肥胖相关指数与心血管疾病风险的关联分析[J]. 实用老年医学, 2025, 39(4): 372-376.
ZHENG Hui, WANG Hui, YIN Donghua, YIN Hongli, SUN Chuqiao,CHENG Yang, WANG Ying. Analysis of the correlation between obesity-related indices and risk of cardiovascular disease in postmenopausal women[J]. Practical Geriatrics, 2025, 39(4): 372-376.
[1] ROTHG A, MENSAH G A, JOHNSON C O, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J].J Am Coll Cardiol, 2020, 76(25): 2982-3021. [2] LEWISS J. Cardiovascular disease in postmenopausal women: myths and reality[J].Am J Cardiol, 2002, 89(12A): 5E-10E;discussion10E-11E. [3] HUANG Y, LIU Y, MA Y, et al. Associations of visceral adipose tissue, circulating protein biomarkers, and risk of cardiovascular diseases: a mendelian randomization analysis[J].Front Cell Dev Biol, 2022, 10: 840866. [4] BEYDOUNM A, WANG Y. Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults[J].Obesity, 2009, 17(1): 169-176. [5] D’AGOSTINO R B, PENCINAM J, MASSARO J M, et al. Cardiovascular disease risk assessment: insights from Framingham[J].Glob Heart, 2013, 8(1): 11-23. [6] VOGEL B, ACEVEDO M, APPELMAN Y, et al. The Lancet Women and Cardiovascular Disease Commission: reducing the global burden by 2030[J].Lancet, 2021, 397(10292): 2385-2438. [7] LI Y, HE Y, YANG L, et al. Body roundness index and waist-hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese cross-sectional study[J].Front Nutr, 2022, 9: 801582. [8] WU Q, ZHANG F, LI R, et al. Identification of the best anthropometric index for predicting the 10-year cardiovascular disease in southwest China: a large single-center, cross-sectional study[J].High Blood Press Cardiovasc Prev, 2022, 29(5): 417-428. [9] BRAND J S, VAN DER SCHOUW Y T. Testosterone, SHBG and cardiovascular health in postmenopausal women[J].Int J Impot Res, 2010, 22(2): 91-104. [10]EL KHOUDARYS R, AGGARWAL B, BECKIE T M, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association[J].Circulation, 2020, 142(25): e506-e532. [11]XU Z, GU S, WU X, et al. Association of follicle stimulating hormone and serum lipid profiles in postmenopausal women[J].Medicine, 2022, 101(39): e30920. [12]EL KHOUDARYS R. HDL and the menopause[J].Curr Opin Lipidol, 2017, 28(4): 328-336. [13]GOLASZEWSKIN M, LACROIX A Z, GODINO J G, et al. Evaluation of social isolation, loneliness, and cardiovascular disease among older women in the US[J].JAMA Netw Open, 2022, 5(2): e2146461. [14]RICO-MARTÍN S, CALDERÓN-GARCÍAJ F, SÁNCHEZ-REY P, et al. Effectiveness of body roundness index in predicting metabolic syndrome: a systematic review and meta-analysis[J].Obes Rev, 2020, 21(7): e13023. [15]LI G, WUH K, WU X W, et al. The feasibility of two anthropometric indices to identify metabolic syndrome, insulin resistance and inflammatory factors in obese and overweight adults[J].Nutrition, 2019, 57: 194-201. [16]LI G, YAO T, WUX W, et al. Novel and traditional anthropometric indices for identifying arterial stiffness in overweight and obese adults[J].Clin Nutr, 2020, 39(3): 893-900. [17]ZHANG S, HAN S, ZHENG L, et al. Associations of trajectories in body roundness index with incident cardiovascular disease: a prospective cohort study in rural China[J].Front Nutr, 2024, 11: 1291093. [18]XU J, ZHANG L, WU Q, et al. Body roundness index is a superior indicator to associate with the cardio-metabolic risk: evidence from a cross-sectional study with 17, 000 Eastern-China adults[J].BMC Cardiovasc Disord, 2021, 21(1): 97. [19]XUE R, LI Q, GENG Y, et al. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies[J].Br J Nutr, 2021, 126(9): 1420-1430. [20]MESERI R, UCKU R, UNAL B. Waist: height ratio: a superior index in estimating cardiovascular risks in Turkish adults[J].Public Health Nutr, 2014, 17(10): 2246-2252. [21]CHENB D, HE C H, MA Y T, et al. Best anthropometric and atherogenic predictors of metabolic syndrome in the Chinese Han population in Xinjiang: the Cardiovascular Risk Survey[J].Ann Nutr Metab, 2014, 65(4): 280-288. [22]FAN H, LI X, ZHENG L, et al. Abdominal obesity is strongly associated with cardiovascular disease and its risk factors in elderly and very elderly community-dwelling Chinese[J].Sci Rep, 2016, 6: 21521. [23]YU J, TAO Y, TAO Y, et al. Optimal cut-off of obesity indices to predict cardiovascular disease risk factors and metabolic syndrome among adults in Northeast China[J].BMC Public Health, 2016, 16(1): 1079. [24]National Institute for Health and Care Excellence(NICE). Obesity: identification, assessment and management.[EB/OL].(2023-07-26)[2024-05-10].https://www.nice.org.uk/guidance/cg189. [25]FENG Q, BEEVIĆ J, CONROY M, et al. Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank[J].Am J Clin Nutr, 2024, 119(6): 1386-1396. [26]ISLAMM T, CHOWDHURY A T, SIRAJ M S, et al. Anthropometric indices in predicting 10-year cardiovascular risk among males and females aged 40-74 years in south and Southeast Asia: analysis of 12 WHO STEPS survey data[J].Lancet Reg Health Southeast Asia, 2024, 29: 100481. [27]PAAJANENT A, OKSALA N K J, KUUKASJÄRVI P, et al. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis[J].Eur Heart J, 2010, 31(14): 1802-1809. [28]HENRIKSSONK M, LINDBLAD U, AGREN B, et al. Associations between body height, body composition and cholesterol levels in middle-aged men. The coronary risk factor study in southern Sweden(CRISS)[J].Eur J Epidemiol, 2001, 17(6): 521-526. |
[1] | 叶佳琦, 严晓云, 姜英, 陈芸, 张清. 层粘连蛋白对急性心力衰竭预后的预测价值[J]. 实用老年医学, 2025, 39(4): 391-394. |
[2] | 江瑞, 高悦, 杜为, 杨浩, 董庆山, 李先进, 李世杰, 韩冰. 老年非瓣膜性心房颤动病人中断抗凝治疗对远期预后的影响[J]. 实用老年医学, 2025, 39(3): 254-257. |
[3] | 任小田, 庄德荣, 王文苑, 蔡定华, 高阳, 马开阳. 纤维化指标-4与老年急性冠脉综合征病人Gensini积分的相关性研究[J]. 实用老年医学, 2025, 39(3): 278-281. |
[4] | 刘玄德, 周世功, 徐祝勤, 单守杰. 外周血清信号蛋白7A在老年急性冠状动脉综合征病人中的表达水平及临床意义[J]. 实用老年医学, 2025, 39(3): 294-297. |
[5] | 鲍磊, 孙才智, 朱晨晨, 秦海东. 血清MPO联合hs-TNT对老年急性心肌梗死病人的诊断价值[J]. 实用老年医学, 2025, 39(2): 144-147. |
[6] | 何玉立, 刘倩慧, 姚子俊, 徐云凡, 吴军. 超声心动图预测老年房颤导管消融术后复发风险的研究进展[J]. 实用老年医学, 2025, 39(2): 207-211. |
[7] | 黄建梅, 郑永. 冠状动脉周围脂肪参数与老年冠心病病人动脉斑块稳定性的关系[J]. 实用老年医学, 2025, 39(1): 66-69. |
[8] | 赵淑晴, 赵莹, 张宇, 卢笑晖. 细胞衰老在慢性心力衰竭中的作用机制研究进展[J]. 实用老年医学, 2025, 39(1): 93-97. |
[9] | 王长远, 赵芯晨, 韩英娜, 刘志. 表现为腹痛、腹泻和短暂一侧肢体无力的老年主动脉夹层1 例报道[J]. 实用老年医学, 2025, 39(1): 104-105. |
[10] | 李玉巧, 陈敏, 王蕾蕾, 周卫华. 即刻药物复律与延迟复律对老年急性阵发性房颤病人预后的影响[J]. 实用老年医学, 2024, 38(12): 1266-1269. |
[11] | 江雨露, 忻笑, 倪雪萍, 崔培荣, 王晴晴, 黄雯妮, 秦世玉, 李贤华. 衰弱在老年冠心病病人久坐行为与生活质量间的中介效应分析[J]. 实用老年医学, 2024, 38(12): 1270-1274. |
[12] | 高文君, 孙青, 刘梦坛, 周丹. 老年慢性心力衰竭病人失志综合征现状及影响因素分析[J]. 实用老年医学, 2024, 38(11): 1105-1109. |
[13] | 闫洪娟, 史朋晓, 宋媛媛, 李艳, 冯丽莎, 罗秋华. 接受ARNI治疗的老年慢性心衰病人死亡风险预测模型的构建[J]. 实用老年医学, 2024, 38(11): 1116-1120. |
[14] | 欧东波, 王琦, 冯光琴, 李维, 黄晓莲, 韦力. 增强型体外反搏治疗老年慢性心力衰竭合并肾功能不全病人的疗效观察[J]. 实用老年医学, 2024, 38(11): 1131-1135. |
[15] | 李晓燕, 郁志明. 老年心房颤动合并焦虑状态的研究进展[J]. 实用老年医学, 2024, 38(10): 979-982. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||
|